S. Michael Rothenberg's most recent trade in Tyra Biosciences Inc was a trade of 13,160 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tyra Biosciences Inc | Dr. S. Michael Rothenberg, M.D.,PhD | Director | 28 May 2026 | 13,160 | 13,160 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. S. Michael Rothenberg, M.D. | Director | 29 May 2025 | 22,200 | 22,200 | - | - | Stock Option (Right to Buy) | ||
| Tyra Biosciences Inc | Dr. S. Michael Rothenberg, M.D. | Director | 07 May 2024 | 37,200 | 37,200 | - | - | Common Stock (Right to Buy) |